🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.370
+0.020 (1.48%)
Nov 18, 2026, 9:36 AM EST - Market open

ADC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
189.2261.34250.87278.6326.44466.54
Cash & Short-Term Investments
189.2261.34250.87278.6326.44466.54
Cash Growth
-19.40%4.17%-9.95%-14.66%-30.03%6.23%
Accounts Receivable
28.4229.1220.3225.1872.9730.22
Other Receivables
-----1.93
Receivables
28.4229.1220.3225.1872.9732.14
Inventory
5.634.182.2516.1812.0711.12
Prepaid Expenses
12.145.618.3710.3423.515.35
Other Current Assets
3.196.089.455.99-0.02
Total Current Assets
238.58306.34291.25336.29434.98525.18
Property, Plant & Equipment
11.313.4316.1310.2611.23
Long-Term Investments
---1.657.6141.24
Other Intangible Assets
-----12.95
Long-Term Deferred Tax Assets
----37.126.05
Long-Term Deferred Charges
-----0.63
Other Long-Term Assets
16.2815.5217.30.710.90.69
Total Assets
255.86323.15321.98354.78490.86617.97

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.589.1818.0315.5712.3512.08
Accrued Expenses
39.3943.3449.8239.1451.9337.77
Current Portion of Long-Term Debt
30.123---13.39
Current Portion of Leases
-0.541.371.471.11.03
Current Income Taxes Payable
-----3.75
Other Current Liabilities
3.0414.1111.2511.516.565.92
Total Current Liabilities
78.1370.1680.4767.6781.9473.94
Long-Term Debt
411.79434.98433.73416.3322.07305.82
Long-Term Leases
-1.03810.186.566.99
Long-Term Unearned Revenue
-----23.54
Pension & Post-Retirement Benefits
-1.941.971.190.053.65
Other Long-Term Liabilities
15.120.870.477.690.7937.95
Total Liabilities
505.04508.98524.62503.03411.41451.88

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11.2611.088.437.317.316.45
Additional Paid-In Capital
1,4511,4401,2841,1811,166981.83
Retained Earnings
-1,711-1,636-1,493-1,335-1,095-924.89
Treasury Stock
-0.19-0.21-0.22-0.54-0.68-0.13
Comprehensive Income & Other
-0.84-0.52-1.42-0.091.82102.83
Shareholders' Equity
-249.17-185.83-202.64-148.2579.45166.09
Total Liabilities & Equity
255.86323.15321.98354.78490.86617.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
441.91439.55443.09427.95329.73327.23
Net Cash (Debt)
-252.71-178.21-192.22-149.35-3.29139.32
Net Cash Growth
------64.94%
Net Cash Per Share
-1.64-1.40-1.98-1.83-0.041.82
Filing Date Shares Outstanding
140.66127.0499.0882.5380.6476.81
Total Common Shares Outstanding
127.74125.7598.8682.2980.6476.81
Working Capital
160.45236.17210.79268.62353.04451.25
Book Value Per Share
-1.95-1.48-2.05-1.800.992.16
Tangible Book Value
-249.17-185.83-202.64-148.2579.45153.14
Tangible Book Value Per Share
-1.95-1.48-2.05-1.800.991.99
Machinery
-1.166.525.944.684.15
Leasehold Improvements
-0.233.873.952.082.25
SEC Filings: 10-K · 10-Q